VEGA THERAPEUTICS
Vega Therapeutics is a biotechnology startup in the clinical stages of creating innovative treatments for uncommon blood disorders.
VEGA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.vega-therapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Google Cloud Gravatar Profiles
Similar Organizations
Allovate
Allovate is a biopharmaceutical company creating innovative treatments for people with allergies.
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.
Emalex Biosciences, Inc.
Emalex Biosciences is a biopharmaceutical company dedicated to the development of new and novel treatments.
Keraderm
Keraderm is a biotechnology company offering phototherapy treatments for skin and nail infections and disorders.
NIMIUM Therapeutics
NIMIUM Therapeutics is a biotech company based in Montreal that is working on developing a novel treatment for cardiometabolic illnesses.
PathMaker Neurosystems
PathMaker Neurosystems is a neurotechnology company that develops treatment for neuromotor disorders.
PIC Therapeutics
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.
Pinteon Therapeutics
Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.
Current Employees Featured
Founder
Investors List
NYBC Ventures
NYBC Ventures investment in Seed Round - Vega Therapeutics
Official Site Inspections
http://www.vega-therapeutics.com Semrush global rank: 8.95 M Semrush visits lastest month: 445
- Host name: 21.90.145.34.bc.googleusercontent.com
- IP address: 34.145.90.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vega Therapeutics"
Vega Therapeutics
We would like to show you a description here but the site won’t allow us.See details»
Vega Therapeutics - PitchBook
Vega Therapeutics was founded in 2018. Where is Vega Therapeutics headquartered? Vega Therapeutics is headquartered in South San Francisco, CA. What industry is Vega Therapeutics in? Vega Therapeutics’s primary …See details»
Vega Therapeutics, Inc. - Drug pipelines, Patents, Clinical ... - Patsnap
Explore Vega Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 9 news, Disease Domain:Hemic and Lymphatic Diseases, Technology …See details»
Vega Therapeutics - LinkedIn
Vega Therapeutics is a clinical stage biotechnology company developing novel, first-in-class therapies for rare blood disorders with overlooked patient needs, starting with von Willebrand disease ...See details»
Vega Therapeutics - Company Profile - Tracxn
Oct 22, 2024 Vega Therapeutics ranks 47th among 62 active competitors. 21 of its competitors are funded while 15 have exited. Overall, Vega Therapeutics and its competitors have raised …See details»
Vega Therapeutics - Tech Stack, Apps, Patents & Trademarks
Vega Therapeutics is a biotechnology startup in the clinical stages of creating innovative treatments for uncommon blood disorders. Search Crunchbase. Start Free Trial . Chrome …See details»
Vega Therapeutics - Funding, Financials, Valuation & Investors
Jan 1, 2022 Vega Therapeutics is a biotechnology startup in the clinical stages of creating innovative treatments for uncommon blood disorders. Search Crunchbase. ... How much …See details»
VEGA THERAPEUTICS LLC: Drug pipelines, Patents, Clinical trials
Jun 13, 2023 Explore VEGA THERAPEUTICS LLC with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Vega Therapeutics launches and unveils its first-in …
Dec 6, 2022 Vega Therapeutics is a clinical stage biotechnology company developing novel, first-in-class therapies for rare blood disorders with overlooked patient needs, starting with von Willebrand disease (VWD). The company’s …See details»
Star Therapeutics adds another $90M to grow its galaxy of drug …
Sep 5, 2023 Star Therapeutics, a biotechnology company building a group of single-drug startups, has raised $90 million to fund and grow its portfolio of subsidiaries. Some of the …See details»
VGA-039 - Drug Targets, Indications, Patents - Synapse - Patsnap
Electra also has preclinical research with an immuno-oncology drug candidate addressing an undisclosed target. Electra has since gone on to raise an $84 million Series B round of …See details»
Star Therapeutics launches Vega, growing its galaxy of drug startups
Dec 6, 2022 Vega Therapeutics is backed by $40 million in financing from Star and many of its investors, among them Westlake Village Biopartners and OrbiMed. The new company is the …See details»
Vega Therapeutics - Contacts, Employees, Board Members
Vega Therapeutics is a biotechnology startup in the clinical stages of creating innovative treatments for uncommon blood disorders. ... Products. Resources. Pricing. Resources. Log …See details»
Vega Therapeutics Receives FDA Orphan Drug Designation for …
May 23, 2023 Vega Therapeutics is a clinical stage biotechnology company developing novel, first-in-class therapies for rare blood disorders with overlooked patient needs, starting with von …See details»
Vega Therapeutics commences VGA039 clinical trial to treat VWD
Apr 7, 2023 Vega Therapeutics chief medical officer Gary Patou said: “We are excited to advance VGA039 into the clinic as the first purpose-built antibody therapy for VWD, …See details»
VEGA THERAPEUTICS LLC - Crunchbase Company Profile & Funding
VEGA THERAPEUTICS LLC is located in San Francisco, California, United States. Who are VEGA THERAPEUTICS LLC 's competitors? Alternatives and possible competitors to VEGA …See details»
Vega Therapeutics Receives FDA Orphan Drug Designation for …
May 23, 2023 Vega Therapeutics is a clinical stage biotechnology company developing novel, first-in-class therapies for rare blood disorders with overlooked patient needs, starting with von …See details»
Vega Therapeutics launches and unveils its first-in-class antibody ...
Dec 6, 2022 About Vega Therapeutics Vega Therapeutics is a clinical stage biotechnology company developing novel, first-in-class therapies for rare blood disorders with overlooked …See details»
Vega Therapeutics Receives Designation for VWD Treatment
May 23, 2023 Vega Therapeutics, a clinical-stage biotechnology company developing novel therapies for rare blood disorders, today announced that the US Food and Drug Administration …See details»